SRTA
Strata Critical Medical, Inc.
NASDAQ · Industrials · Airlines, Airports & Air Services · US
$5.18
+16.64%Year over year
Reported trailing growth
- Revenue
- +22.7%
- EBITDA
- +71.8%
- EBIT
- +29.8%
- EPS
- —
- Free cash flow
- +100.7%
- Operating cash flow
- +129.6%
Forward estimates
Based on analyst estimates
- Revenue
- +13.4%
- EBITDA
- +816.3%
- EPS
- +120.6%
Three-year CAGR
- Revenue
- +10.5%
- EBITDA
- +73.6%
- EBIT
- +34.1%
- Net income
- +251.4%
- EPS
- +242.9%
- Free cash flow
- -68.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026